The World Health Organization (WHO) released its first-ever guideline on using GLP-1 medications to treat obesity.

LONDON, Sept 5 (Reuters) - The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list, alongside treatments for cystic fibrosis and cancer, and said it hopes ...

The World Health Organization on Monday recommended GLP-1 drugs as a tool to manage obesity in adults, marking a shift in the ...

The World Health Organisation has added GLP-1 drugs to treat diabetes, as well as treatments for cystic fibrosis and cancer, to its essential medicines list, aiming to boost global access to these ...

The U.S. Food and Drug Administration on Friday established a "green list" import alert to help stop potentially dangerous GLP-1 (glucagon-like peptide-1) active pharmaceutical ingredients (APIs) from ...

Health authorities around the world have received a new roadmap for addressing obesity, as the World Health Organisation ...

The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly and Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world. The ...

The guideline specifies that drugs alone are not enough and emphasizes the need for behavioral and lifestyle interventions.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

(NewsNation) — The World Health Organization has added drugs intended to treat diabetes to its essential medicines list in hopes the classification will improve global access to the costly drugs. The ...